HealthCCSng vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

HealthCCSng

by Nano-X AI

Tempus ECG-AF

by Tempus AI, Inc.

AI Verdict

These two healthcare-AI tools are adjacent in their comparability. While both are FDA-cleared AI solutions within cardiology, HealthCCSng focuses on detecting and quantifying coronary artery calcification from CT scans to assess coronary artery disease risk. In contrast, Tempus ECG-AF analyzes 12-lead ECGs to identify older patients at risk of developing atrial fibrillation/flutter.

Choose HealthCCSng if…

Choose HealthCCSng if your primary goal is to opportunistically assess a patient's risk of coronary artery disease by leveraging existing routine chest CT scans, even those performed for non-cardiac indications. This tool is ideal for automatically quantifying coronary artery calcification and generating a calcium score without requiring dedicated cardiac imaging protocols.

View HealthCCSng →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if you need to identify older patients (65+) at increased risk of developing new-onset atrial fibrillation within the next year, utilizing standard 12-lead ECG recordings. This solution is best suited for proactive screening and follow-up planning in a geriatric population where early AF detection can significantly impact patient management.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	HealthCCSng	Tempus ECG-AF
Pricing	Not publicly available	Contact vendor
Deployment	Cloud-based, integrates with PACS and EMR systems	Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

HealthCCSng

HealthCCSng boasts an automated workflow that analyzes CT scans and provides results without human intervention, seamlessly integrating with PACS and EMR systems. This suggests a highly efficient and hands-off user experience. Tempus ECG-AF, while integrated, requires results to be interpreted in conjunction with other diagnostic information, implying a necessary human review step.

Clinical Value

Tie

Both tools offer significant clinical value by addressing critical cardiovascular health concerns. HealthCCSng identifies patients at risk of coronary artery disease by detecting and quantifying coronary artery calcification from routine CT scans. Tempus ECG-AF identifies patients aged 65 or older at increased risk of developing atrial fibrillation/flutter within 12 months, enabling earlier intervention for a condition that can lead to stroke. Both contribute substantially to proactive patient care.

Pricing & Value

Tempus ECG-AF

Tempus ECG-AF provides greater transparency regarding its value proposition by explicitly stating CMS reimbursement availability (CPT 0764T and CPT 0765T to APC 5734, Medicare rate of $128.90, effective January 1, 2025). While HealthCCSng has CPT Category III codes for reimbursement, it does not publicly disclose specific pricing or reimbursement rates, making its financial value less clear upfront.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and designed for integration with existing healthcare systems. HealthCCSng is cloud-based and integrates with PACS and EMR, while Tempus ECG-AF is a software solution integrated into facility systems. Both are well-positioned for deployment in healthcare environments.

Innovation

Tempus ECG-AF

While both are innovative, Tempus ECG-AF's ability to predict the *future onset* of atrial fibrillation within 12 months from a standard 12-lead ECG represents a slightly more advanced application of predictive AI in cardiology. HealthCCSng innovatively leverages routine CT scans for incidental CAC detection, but Tempus ECG-AF's predictive capability for a future event pushes the boundary of current diagnostic AI.

Support & Docs

Tempus ECG-AF

Tempus AI provides a more visible and structured support framework, including a 'Notetaker Support' page with FAQs and a dedicated support email, as well as a 'Document Library' with technical information for its products. Nano-X AI's website offers general contact information but lacks specific, publicly accessible support documentation or a dedicated support portal for HealthCCSng.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	HealthCCSng	Tempus ECG-AF
Tool Name	HealthCCSng	Tempus ECG-AF
Company	Nano-X AI	Tempus AI, Inc.
Core Function/Detection	Analyzes CT scans to detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease.	Analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Primary Input Data	Routine non-contrast, non-ECG gated chest CT scans	12-lead ECG recordings
Target Patient Population/Use Case	Patients at risk of coronary artery disease (CAC assessment)	Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, for AF risk identification.
Specialties	Cardiology, Radiology	Cardiology, Geriatrics, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring HealthCCSng and Tempus ECG-AF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of HealthCCSng versus Tempus ECG-AF?

HealthCCSng is an AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease. Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.

What type of patient data is required for each tool?

HealthCCSng analyzes routine non-contrast, non-ECG gated chest CT scans that include the entire heart of adult patients. Tempus ECG-AF requires 12-lead ECG recordings, specifically compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems.

For which patient populations are these tools intended?

HealthCCSng is intended for adult patients aged 30-85 years undergoing routine CT scans to assess their risk of coronary artery disease. Tempus ECG-AF is intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.

How do the outputs of these tools differ in supporting clinical decision-making?

HealthCCSng generates a numerical calcium score, categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, and provides visualization of calcified plaques. Tempus ECG-AF detects signs associated with new onset Atrial Fibrillation within 12 months, with results interpreted in conjunction with other diagnostic information and clinical history.

What are the integration and workflow implications for each tool?

HealthCCSng is cloud-based and integrates seamlessly with PACS and EMR systems, offering an automated workflow for results without human intervention. Tempus ECG-AF is a software solution integrated into healthcare facility systems with advanced cardiology algorithms, and its results are returned to users via standard communication protocols.

Is there specific reimbursement available for using these tools?

Tempus ECG-AF has CMS reimbursement available, with CPT codes 0764T and 0765T mapping to APC 5734, and a Medicare rate of $128.90 effective January 1, 2025. HealthCCSng has Category III CPT codes (0721T and 0722T) establishing a reimbursement pathway, but its specific pricing is not publicly available.

What are the technical requirements for the input data for each tool?

HealthCCSng analyzes non-contrast, non-ECG gated chest CT scans. Tempus ECG-AF requires data and metadata from a 10-second 12-lead resting electrocardiogram recording, and is compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems.